MA46239A - Mousse pharmaceutique stable - Google Patents
Mousse pharmaceutique stableInfo
- Publication number
- MA46239A MA46239A MA046239A MA46239A MA46239A MA 46239 A MA46239 A MA 46239A MA 046239 A MA046239 A MA 046239A MA 46239 A MA46239 A MA 46239A MA 46239 A MA46239 A MA 46239A
- Authority
- MA
- Morocco
- Prior art keywords
- stable pharmaceutical
- pharmaceutical foam
- foam
- stable
- pharmaceutical
- Prior art date
Links
- 239000008255 pharmaceutical foam Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/122—Foams; Dry foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/363—Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4833—Thrombin (3.4.21.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0028—Polypeptides; Proteins; Degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0028—Polypeptides; Proteins; Degradation products thereof
- A61L26/0042—Fibrin; Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0028—Polypeptides; Proteins; Degradation products thereof
- A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0085—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/04—Materials for stopping bleeding
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Materials Engineering (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Dispersion Chemistry (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662394371P | 2016-09-14 | 2016-09-14 | |
IL247810A IL247810A0 (en) | 2016-09-14 | 2016-09-14 | Stable pharmaceutical foam |
Publications (1)
Publication Number | Publication Date |
---|---|
MA46239A true MA46239A (fr) | 2019-07-24 |
Family
ID=60022140
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA046239A MA46239A (fr) | 2016-09-14 | 2017-09-11 | Mousse pharmaceutique stable |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP3512502A1 (ko) |
JP (1) | JP7114597B2 (ko) |
KR (1) | KR102656742B1 (ko) |
CN (1) | CN109789091A (ko) |
AU (1) | AU2017328480A1 (ko) |
CA (1) | CA3036770A1 (ko) |
IL (1) | IL265252B2 (ko) |
MA (1) | MA46239A (ko) |
WO (1) | WO2018051325A1 (ko) |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2492458A (en) | 1944-12-08 | 1949-12-27 | Jr Edgar A Bering | Fibrin foam |
CH264752A (de) * | 1947-06-03 | 1949-10-31 | Hoffmann La Roche | Verfahren zur Herstellung von Trägern für Arzneimittel. |
JPS5814813B2 (ja) * | 1976-11-09 | 1983-03-22 | 味の素株式会社 | 起泡剤及びその製造法 |
US6454787B1 (en) | 1998-12-11 | 2002-09-24 | C. R. Bard, Inc. | Collagen hemostatic foam |
EP1115434B1 (fr) | 1999-07-21 | 2005-05-25 | Imedex Biomateriaux | Mousse proteique adhesive a usage chirurgical et/ou therapeutique |
AU2001241644A1 (en) | 2000-02-25 | 2001-09-03 | David Sierra | Foam-forming wound dressing |
ATE329953T1 (de) | 2001-03-26 | 2006-07-15 | Bayer Materialscience Ag | Polycarbonat mit ausgeprägtem scherentzähungsverhalten |
US8741335B2 (en) | 2002-06-14 | 2014-06-03 | Hemcon Medical Technologies, Inc. | Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as Chitosan |
US6749842B2 (en) * | 2002-01-24 | 2004-06-15 | Midwest Grain Products | Liquid foam builder containing hydrolyzed grain protein |
US8202549B2 (en) | 2007-08-14 | 2012-06-19 | The Regents Of The University Of California | Mesocellular oxide foams as hemostatic compositions and methods of use |
JP2012512812A (ja) * | 2007-12-28 | 2012-06-07 | クロス・バイオサージェリー・アクチェンゲゼルシャフト | フィブリンフォームに組込まれたpdgf融合タンパク質 |
US8642831B2 (en) * | 2008-02-29 | 2014-02-04 | Ferrosan Medical Devices A/S | Device for promotion of hemostasis and/or wound healing |
CA2717571C (en) * | 2008-03-03 | 2016-08-23 | Omrix Biopharmaceuticals Ltd. | A gelatin sponge comprising an active ingredient, its preparation and use |
US8512740B2 (en) | 2008-03-26 | 2013-08-20 | Baxter International Inc. | Fibrin foam and process for making |
US8753670B2 (en) | 2008-03-26 | 2014-06-17 | Baxter International Inc. | Fibrin foam and process |
US20110036133A1 (en) * | 2008-04-18 | 2011-02-17 | N. V. Organon | Purification of protein hydrolysate and the result and products |
US20100021527A1 (en) | 2008-07-25 | 2010-01-28 | Chunlin Yang | Collagen-related peptides and uses thereof and hemostatic foam substrates |
US8778883B2 (en) | 2009-11-13 | 2014-07-15 | Industrial Technology Research Institute | Foamy biomaterial for biological tissue repair |
RU2013155713A (ru) * | 2011-07-06 | 2015-08-20 | Профибрикс Бв | Составы для лечения ран |
US8680240B1 (en) * | 2012-11-01 | 2014-03-25 | George David Falus | Tissue sealant for use in non-compressible hemorrhage |
BR112015012985B8 (pt) | 2012-12-07 | 2020-04-14 | Baxter Healthcare Sa | método para preparar uma espuma líquida hemostática farmacêutica, combinação de produto, espuma líquida hemostática farmacêutica transiente, kit para produzir uma espuma líquida hemostática farmacêutica transiente, e, uso de uma preparação farmacêutica |
CN105543315A (zh) * | 2015-12-16 | 2016-05-04 | 陕西科技大学 | 胶原蛋白类发泡剂、其复配改性发泡剂以及二者的制备方法 |
-
2017
- 2017-09-11 WO PCT/IL2017/000007 patent/WO2018051325A1/en unknown
- 2017-09-11 IL IL265252A patent/IL265252B2/en unknown
- 2017-09-11 CN CN201780056569.1A patent/CN109789091A/zh active Pending
- 2017-09-11 AU AU2017328480A patent/AU2017328480A1/en not_active Abandoned
- 2017-09-11 EP EP17780529.8A patent/EP3512502A1/en not_active Withdrawn
- 2017-09-11 MA MA046239A patent/MA46239A/fr unknown
- 2017-09-11 CA CA3036770A patent/CA3036770A1/en not_active Abandoned
- 2017-09-11 JP JP2019536003A patent/JP7114597B2/ja active Active
- 2017-09-11 KR KR1020197010499A patent/KR102656742B1/ko active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
IL265252B2 (en) | 2023-11-01 |
JP2019526646A (ja) | 2019-09-19 |
IL265252A (en) | 2019-05-30 |
KR102656742B1 (ko) | 2024-04-15 |
IL265252B1 (en) | 2023-07-01 |
EP3512502A1 (en) | 2019-07-24 |
AU2017328480A1 (en) | 2019-03-14 |
CA3036770A1 (en) | 2018-03-22 |
WO2018051325A1 (en) | 2018-03-22 |
KR20190054110A (ko) | 2019-05-21 |
JP7114597B2 (ja) | 2022-08-08 |
CN109789091A (zh) | 2019-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112018009951A2 (pt) | fármaco oftálmico | |
DK3479819T3 (da) | Stabilt væskeformigt farmaceutisk præparat | |
DK3529248T3 (da) | Farmaceutiske sammensætninger | |
DK3328880T3 (da) | Terapeutiske midler | |
MA50541A (fr) | Formulations pharmaceutiques | |
MA46334A (fr) | Composition pharmaceutique liquide | |
DK3634377T3 (da) | Farmaceutisk formulering | |
DK3529240T3 (da) | Farmaceutiske forbindelser | |
MA42303A (fr) | Formulations pharmaceutiques | |
MA43375A (fr) | Mousse minérale ultra-légère | |
MA46867A (fr) | Formulations pharmaceutiques | |
MA43705A (fr) | Formulation pharmaceutique | |
DK3463345T3 (da) | Farmaceutiske kombinationer | |
DK3199161T3 (da) | Farmaceutisk præparat | |
MA44987A (fr) | Formulations de médicaments améliorées | |
DK3525897T3 (da) | Spilsystem | |
DK3679010T3 (da) | Kulsyre-additionsprodukter | |
MA42964A (fr) | Préparation pharmaceutique anti-vieillissement | |
MA47516A (fr) | Composition pharmaceutique | |
IL266537A (en) | pharmaceutical preparation | |
MA49822A (fr) | Combinaison pharmaceutique comprenant du ponesimod | |
DK3280447T3 (da) | Farmaceutiske formuleringer | |
ZA201807851B (en) | Pharmaceutical formulation | |
DK3601277T3 (da) | Farmaceutisk formulering | |
CL2016002705A1 (es) | Formulación agroquímica |